Advances in understanding of fragile X pathogenesis and FMRP function, and in identification of X linked mental retardation genes

Current Opinion in Genetics and Development

Volumn 12, Issue 3, 2002, Pages 284-293

  Bardoni, Barbara ^a   Mandel, Jean Louis ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MESSENGER RNA; FMR1 PROTEIN, HUMAN; NERVE PROTEIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; RNA BINDING PROTEIN;

CELL MATURATION; CLINICAL FEATURE; FRAGILE X SYNDROME; HUMAN; MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; TRANSLATION REGULATION; BRAIN; GENETICS; MENTAL DEFICIENCY; METABOLISM; TRINUCLEOTIDE REPEAT;

BRAIN; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; MENTAL RETARDATION; MUTATION; NERVE TISSUE PROTEINS; PHENOTYPE; RHO GTP-BINDING PROTEINS; RNA-BINDING PROTEINS; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 0036591664     PISSN: 0959437X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-437X(02)00300-3     Document Type: Review

References (93)

1. Monogenic causes of X-linked mental retardation
2. FMR1 and mutations in fragile X syndrome: Molecular biology, biochemistry, and genetics
3. Understanding the molecular basis of fragile X syndrome
4. FMR1 gene and fragile X syndrome
5. FMR1 and the fragile X syndrome: Human genome epidemiology review
6. Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells
7. Interaction of the transcription factors USF1, USF2, and alpha-Pal/Nrf-1 with the FMR1 promoter. Implications for Fragile X mental retardation syndrome
8. Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene
9. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation
10. Immunocytochemical and biochemical characterization of FMRP, FXR1P, and FXR2P in the mouse
11. + mRNA in actively translating polyribosomes
12. FMRP associates with polyribosomes as an mRNP, and the I304N mutation of severe fragile X syndrome abolishes this association
13. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation
14. Fragile X mental retardation protein: Nucleocytoplasmic shuttling and association with somatodendritic ribosomes
15. The Fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals
16. Analysis of domains affecting intracellular localization of the FMRP protein
17. A nuclear role for the Fragile X mental retardation protein
18. Different targets for the fragile X related proteins revealed by distinct nuclear localization
19. Comparative genomic sequence analysis of the FXR gene family: FMR1, FXR1, and FXR2
20. Characterization of dFMR1, a Drosophila melanogaster homolog of the fragile X mental retardation protein
21. Oligomerization properties of fragile-X mental-retardation protein (FMRP) and the fragile-X-related proteins FXR1P and FXR2P
22. FMR1 knockout mice: A model to study fragile X mental retardation
23. Translational suppression by trinucleotide repeat expansion at FMR1
24. Normal phenotype in two brothers with a full FMR1 mutation
25. Obstetrical and gynecological complications in fragile X carriers: A multicenter study
26. Premature ovarian failure in fragile X syndrome
27. Fragile X premutations in familial premature ovarian failure
28. Imprinting effect in premature ovarian failure confined to paternally inherited fragile X premutations
29. Premature ovarian failure among fragile X premutation carriers: Parent-of-origin effect?
30. Elevated levels of FMR1 mRNA in carrier males: A new mechanism of involvement in the fragile-X syndrome
31. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers
32. Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: A clue to the sex bias in the transmission of full mutations?
33. Quantitative comparison of FMR1 gene expression in normal and premutation alleles
34. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X
35. Neuropathology and neurodegenerative features in some older male premutation carriers of fragile X syndrome
36. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy
37. Reproductive and menstrual history of females with fragile X expansions
38. Instability of a (CGG)98 repeat in the Fmr1 promoter
39. Evidence of Cis-acting factors in replication-mediated trinucleotide repeat instability in primate cells
40. Mitotic behavior of expanded CGG repeats studied on cultured cells: Further evidence for methylation-mediated triplet repeat stability in fragile X syndrome
41. Demethylation reactivation, and destabilization of human fragile X full-mutation alleles in mouse embryocarcinoma cells
42. FMR1 CGG-repeat instability in single sperm and lymphocytes of fragile-X premutation males
43. Factors involved in the initial mutation of the fragile X CGG repeat as determined by sperm small pool PCR
44. FMR1 protein: Conserved RNP family domains and selective RNA binding
45. Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein
46. Isolation of an FMRP-associated messenger ribonucleoprotein particle and identification of nucleolin and the fragile X related proteins as components of the complex
47. RNAs that interact with the fragile-X syndrome RNA binding protein FMRP
48. The Fragile X mental retardation protein interacts specifically with its own mRNA via a purine-quartet structure
49. Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function
50. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome
51. Evidence that fragile X mental retardation protein is a negative regulator of translation
52. The fragile X mental retardation protein inhibits translation via interacting with mRNA
53. Drosophila Fragile X-related gene regulates MAP1B homolog Futsch to control synaptic structure and function
54. Using 2D gel analysis of wildtype and Fmr1 knockout mouse hippocampus to identify differentially expressed proteins
55. A novel RNA-binding nuclear protein that interacts with the fragile X mental retardation (FMR1) protein
56. The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2
57. Novel isoforms of the fragile X related protein FXR1P are expressed during myogenesis
58. Developmental expression of the fragile X mental retardation proteins in mouse testis: Localization to microtubules elements in spermatozoa
59. The fragile X-related proteins FXR1P and FXR2P contain a functional nucleolar-targeting signal equivalent to the HIV-1 regulatory proteins
60. Knockout mouse model for Fxr2: A model for mental retardation
61. A highly conserved protein family interacting with the fragile X mental retardation protein and displaying selective Interactions with the FMRP related proteins FXR1P and FXR2P
62. P140Sra-1 (Specifically Rac1-associated protein) is a novel specific target for Rac1 small GTPase
63. Rho GTPases in neuronal morphogenesis
64. Identification of mouse YB1/p50 as a component of the FMRP-associated mRNP particles
65. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T-cell activation
66. Fragile X mouse: Strain effects of knockout phenotype and evidence suggesting deficient amygdala function
67. Spatial learning, contextual fear conditioning and conditioned emotional response in Fmr1 knockout mice
68. Fmr1 knockout mouse has a distinctive strain-specific learning impairment
69. Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome
70. Fragile X mice develop sensory hyperreactivity to auditory stimuli
71. Alterations in the auditory startle response in Fmr1 targeted mouse model of fragile X syndrome
72. (Over)correction of FMR1 deficiency with YAC transgenic: Behavioral and physical features
73. Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits
74. Synaptic regulation of protein synthesis and the fragile X protein
75. Analysis of neocortex in three males with the fragile X syndrome
76. Abnormal dendritic spine characteristics in temporal and visual cortices of patients with fragile-X syndrome: A quantitative examination
77. Abnormal development of dendritic spines in FMR1 knock-out mice
78. Evidence for altered fragile-X mental retardation protein expression in response to behavioral stimulation
79. Sensory stimulation increases cortical expression of the fragile X mental retardation protein in vivo
80. Long-term potentiation in the hippocampus of fragile X knockout mice
81. Reduced cortical synaptic plasticity and GluR1 expression associated with fragile X mental retardation protein deficiency
82. Altered synaptic plasticity in a mouse model of fragile X mental retardation
83. Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy
84. ARX, a novel prd-class-homeobox gene highly expressed in the telencephalon, is mutated in X-linked mental retardation
85. FACL4, encoding fatty acids ligase type 4, is a new MRX gene
86. X-linked creatine-transporter gene (SLC6A8) defect: A new creatine-deficiency syndrome
87. Mutations in the creatine transporter gene (SLC6A8) in Xq28 cause X-linked mental retardation: The important role of creatine metabolism in brain function
88. MECP2 is highly mutated in X-linked mental retardation
89. High frequency of MECP2 mutations in mentally retarded males: Implications for routine DNA diagnostics
90. Dissecting FMR1, the protein responsible for fragile X syndrome, in its structural and functional domains